FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Droge, W.
Right arrow Articles by Holm, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Droge, W.
Right arrow Articles by Holm, E.

The FASEB Journal, Vol 11, 1077-1089, Copyright © 1997 by The Federation of American Societies for Experimental Biology


REVIEWS

Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction

W Droge and E Holm
Division of Immunochemistry, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

The combination of abnormally low plasma cystine and glutamine levels, low natural killer (NK) cell activity, skeletal muscle wasting or muscle fatigue, and increased rates of urea production defines a complex of abnormalities that is tentatively called "low CG syndrome." These symptoms are found in patients with HIV infection, cancer, major injuries, sepsis, Crohn's disease, ulcerative colitis, chronic fatigue syndrome, and to some extent in overtrained athletes. The coincidence of these symptoms in diseases of different etiological origin suggests a causal relationship. The low NK cell activity in most cases is not life-threatening, but may be disastrous in HIV infection because it may compromise the initially stable balance between the immune system and virus, and trigger disease progression. This hypothesis is supported by the coincidence observed between the decrease of CD4+ T cells and a decrease in the plasma cystine level. In addition, recent studies revealed important clues about the role of cysteine and glutathione in the development of skeletal muscle wasting. Evidence suggests that 1) the cystine level is regulated primarily by the normal postabsorptive skeletal muscle protein catabolism, 2) the cystine level itself is a physiological regulator of nitrogen balance and body cell mass, 3) the cyst(e)ine-mediated regulatory circuit is compromised in various catabolic conditions, including old age, and 4) cysteine supplementation may be a useful therapy if combined with disease- specific treatments such as antiviral therapy in HIV infection.


This article has been cited by other articles:


Home page
QJMHome page
W.S. Waring, A.F.L. Stephen, O.D.G. Robinson, M.A. Dow, and J.M. Pettie
Serum urea concentration and the risk of hepatotoxicity after paracetamol overdose
QJM, May 1, 2008; 101(5): 359 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. S. Nkabyo, L. H. Gu, D. P. Jones, and T. R. Ziegler
Thiol/Disulfide Redox Status Is Oxidized in Plasma and Small Intestinal and Colonic Mucosa of Rats with Inadequate Sulfur Amino Acid Intake
J. Nutr., May 1, 2006; 136(5): 1242 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Melendez, R. Blanco, W. Delgado, R. Garcia, J. Santana, H. Garcia, O. Rosario, and J. F. Rodriguez
Lack of Evidence for In Vivo Transformation of Zidovudine Triphosphate to Stavudine Triphosphate in Human Immunodeficiency Virus-Infected Patients
Antimicrob. Agents Chemother., March 1, 2006; 50(3): 835 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. T. Miller, W. H. Watson, W. G. Kirlin, T. R. Ziegler, and D. P. Jones
Oxidation of the Glutathione/Glutathione Disulfide Redox State Is Induced by Cysteine Deficiency in Human Colon Carcinoma HT29 Cells
J. Nutr., August 1, 2002; 132(8): 2303 - 2306.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
W. Droge
Free Radicals in the Physiological Control of Cell Function
Physiol Rev, January 1, 2002; 82(1): 47 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. R. Young and A. M. Ajami
Glutamine: The Emperor or His Clothes?
J. Nutr., September 1, 2001; 131(9): 2449S - 2459.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. C. Lands, V. L. Grey, and A. A. Smountas
Effect of supplementation with a cysteine donor on muscular performance
J Appl Physiol, October 1, 1999; 87(4): 1381 - 1385.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. C. Lands, V. Grey, A. A. Smountas, V. G. Kramer, and D. McKenna
Lymphocyte Glutathione Levels in Children With Cystic Fibrosis
Chest, July 1, 1999; 116(1): 201 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sato, M. Tamba, T. Ishii, and S. Bannai
Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins
J. Biol. Chem., April 23, 1999; 274(17): 11455 - 11458.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Hack, R. Breitkreutz, R. Kinscherf, H. Rohrer, P. Bartsch, F. Taut, A. Benner, and W. Droge
The Redox State as a Correlate of Senescence and Wasting and as a Target for Therapeutic Intervention
Blood, July 1, 1998; 92(1): 59 - 67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The Federation of American Societies for Experimental Biology.